GUO Yi, LI Jun-xiang, MAO Tang-you, et al. Effect of Combined Prescription of Linggui Zhugan Tang and Yinchenhao Tang on Nrf2/ARE Signaling Pathway in Rats with Non-alcoholic Steatohepatitis[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(16): 108-113.
GUO Yi, LI Jun-xiang, MAO Tang-you, et al. Effect of Combined Prescription of Linggui Zhugan Tang and Yinchenhao Tang on Nrf2/ARE Signaling Pathway in Rats with Non-alcoholic Steatohepatitis[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(16): 108-113. DOI: 10.13422/j.cnki.syfjx.2017160108.
Objective: To observe the effects of combined prescription of Linggui Zhugan Tang (LGZGT) and Yinchenhao Tang (YCHT) on Nrf2/ARE signaling pathway in rats with non-alcoholic steatohepatitis (NASH) from the perspective of oxidative stress
and investigate its mechanism for treating non-alcoholic steatohepatitis. Method: SPF grade SD rats were randomly divided into normal control group
model group
sulforaphane group (0.5 mg·kg-1)
LGZGT group (3.465 g·kg-1)
YCHT group (3.465 g·kg-1) and LGZGT+YCHT combination group (6.93 g·kg-1). High-fat diet was given to establish NASH models
and the treatment was given at the same time for 8 weeks. Then the serum was harvested separately to detect the levels of alanine aminotransferase (ALT)
aspartate aminotransferase (AST)
total cholesterol (TC)
triglyceride (TG)
high-density lipoprotein (HDL-C)
and low density lipoprotein (LDL-C); part liver tissues were taken for HE staining; Western blot and reverse transcription PCR were used respectively to detect the protein and mRNA expression levels of Kelch-like ECH-associated protein 1 (Keap1)
nuclear factor E2-related factor 2 (Nrf2)
quinone oxidoreductase-1 (NQO1)
and heme oxygenase-1 (HO-1). Result: As compared with normal control group
the levels of TC
TG
HDL-C and LDL-C in blood lipid and ALT
AST levels in serum were increased;liver fat became obvious; the expression level of Keap1 in liver was decreased; and
Nrf2
NQO1
HO-1 protein and mRNA expression levels were increased in the model group (P <0.05).As compared with the model group
the levels of TC
TG
HDL-C and LDL-C in blood lipid and ALT
AST levels in serum were decreased in various treatment groups
liver pathology was also improved to some extent; and Nrf2
NQO1
HO-1 protein and mRNA expression levels were increased in treatment groups (P <0.01
P <0.05) except YCHT group. However
the levels of Keap1 didn't show obvious differences among the treatment groups. Conclusion: LGZGT and its combination formula may improve oxidative stress to prevent and treat NASH via activating Nrf2/ARE signaling pathway in the liver.